X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (56104) 56104
Publication (5986) 5986
Newspaper Article (852) 852
Book Chapter (563) 563
Book Review (386) 386
Dissertation (208) 208
Conference Proceeding (108) 108
Web Resource (84) 84
Book / eBook (80) 80
Magazine Article (69) 69
Government Document (57) 57
Trade Publication Article (37) 37
Data Set (34) 34
Streaming Video (21) 21
Paper (9) 9
Journal / eJournal (7) 7
Report (4) 4
Computer File (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (30603) 30603
index medicus (23110) 23110
multidrug-resistance (15652) 15652
multidrug resistance (15025) 15025
animals (11801) 11801
drug resistance (11067) 11067
p-glycoprotein (10718) 10718
pharmacology & pharmacy (10632) 10632
female (10220) 10220
male (9438) 9438
microbiology (7575) 7575
oncology (7116) 7116
infectious diseases (6936) 6936
cancer (6357) 6357
tuberculosis (6176) 6176
adult (5974) 5974
biochemistry & molecular biology (5936) 5936
expression (5805) 5805
drug resistance in microorganisms (5641) 5641
middle aged (5299) 5299
chemotherapy (4915) 4915
mice (4555) 4555
drug-resistance (4502) 4502
research (4466) 4466
analysis (4252) 4252
cell line, tumor (4210) 4210
microbial sensitivity tests (4023) 4023
antibiotics (3795) 3795
bacteria (3613) 3613
proteins (3607) 3607
tuberculosis, multidrug-resistant - drug therapy (3551) 3551
aged (3542) 3542
in-vitro (3533) 3533
apoptosis (3350) 3350
anti-bacterial agents - pharmacology (3165) 3165
antitubercular agents - therapeutic use (3155) 3155
drug resistance, neoplasm (3111) 3111
drug resistance, multiple (3096) 3096
antineoplastic agents - pharmacology (3073) 3073
mycobacterium tuberculosis - drug effects (3030) 3030
health aspects (2984) 2984
atp-binding cassette, sub-family b, member 1 - metabolism (2895) 2895
drugs (2889) 2889
escherichia-coli (2888) 2888
mutation (2873) 2873
medicine (2867) 2867
cells (2822) 2822
gene expression (2814) 2814
multidrug-resistant (2712) 2712
gene (2707) 2707
infections (2645) 2645
adolescent (2614) 2614
multidrug resistance-associated proteins - genetics (2587) 2587
multidrug resistance-associated proteins - metabolism (2582) 2582
tuberculosis, multidrug-resistant - epidemiology (2580) 2580
doxorubicin (2570) 2570
cell biology (2566) 2566
genes (2557) 2557
epidemiology (2521) 2521
research article (2512) 2512
genetic aspects (2434) 2434
article (2399) 2399
multidrug-resistant tuberculosis (2353) 2353
chemistry, medicinal (2339) 2339
risk factors (2337) 2337
drug therapy (2336) 2336
multidrug resistant organisms (2323) 2323
atp-binding cassette transporters - metabolism (2317) 2317
resistance (2298) 2298
care and treatment (2297) 2297
drug resistance, multiple, bacterial (2290) 2290
tumor cells, cultured (2284) 2284
multidisciplinary sciences (2186) 2186
rats (2184) 2184
respiratory system (2155) 2155
immunology (2147) 2147
treatment outcome (2143) 2143
atp-binding cassette transporters - genetics (2129) 2129
prevalence (2111) 2111
mycobacterium-tuberculosis (2085) 2085
atp-binding cassette, sub-family b, member 1 - genetics (2044) 2044
antimicrobial resistance (2032) 2032
tuberculosis, multidrug-resistant - microbiology (1980) 1980
antitubercular agents - pharmacology (1963) 1963
molecular sequence data (1963) 1963
child (1893) 1893
dose-response relationship, drug (1874) 1874
mycobacterium tuberculosis (1871) 1871
pharmacokinetics (1870) 1870
transporter (1857) 1857
chemistry, multidisciplinary (1821) 1821
medicine, research & experimental (1810) 1810
doxorubicin - pharmacology (1797) 1797
genotype (1786) 1786
antimicrobial agents (1784) 1784
physiological aspects (1758) 1758
identification (1748) 1748
young adult (1722) 1722
polymerase chain reaction (1720) 1720
protein (1698) 1698
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (49) 49
Gerstein Science - Stacks (38) 38
West Park Healthcare Centre - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Robarts - Government Pubs (3) 3
Scarborough Hospital - Online (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Media Commons - Microtexts (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (55163) 55163
Chinese (425) 425
French (400) 400
Spanish (382) 382
Japanese (371) 371
German (292) 292
Russian (247) 247
Korean (156) 156
Portuguese (140) 140
Polish (104) 104
Turkish (69) 69
Italian (46) 46
Czech (36) 36
Romanian (23) 23
Hungarian (18) 18
Dutch (16) 16
Swedish (15) 15
Ukrainian (12) 12
Danish (9) 9
Persian (9) 9
Norwegian (8) 8
Arabic (7) 7
Slovak (7) 7
Croatian (6) 6
Bosnian (5) 5
Lithuanian (5) 5
Finnish (4) 4
Serbian (4) 4
Icelandic (2) 2
Amharic (1) 1
Galician (1) 1
Indonesian (1) 1
Slovenian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Health Services Research, ISSN 1472-6963, 04/2017, Volume 17, Issue 1, pp. 249 - 9
Journal Article
Indian Journal of Medical Research, ISSN 0971-5916, 08/2017, Volume 145, Issue March, pp. 271 - 293
Emergence of extensively drug-resistant tuberculosis (XDR-TB) has significantly threatened to jeopardize global efforts to control TB, especially in HIV... 
Line drugs | Pregnancy | Multidrug | Resistant tuberculosis | HIV | Second | Diagnosis | XDR-TB | Epidemiology | Extensively drug | India | MYCOBACTERIUM-TUBERCULOSIS | MEDICINE, RESEARCH & EXPERIMENTAL | MULTIDRUG-RESISTANT | RISK-FACTORS | TREATMENT OUTCOMES | pregnancy | MDR-TB | multidrug-resistant tuberculosis | IMMUNOLOGY | CLINICAL MANAGEMENT | epidemiology | MEDICINE, GENERAL & INTERNAL | extensively drug resistant tuberculosis | IMPACT | SURVEILLANCE | RUSSIA | second-line drugs | HIV Infections - epidemiology | HIV Infections - virology | Humans | Risk Factors | India - epidemiology | HIV - pathogenicity | Tuberculosis, Multidrug-Resistant - epidemiology | Tuberculosis, Multidrug-Resistant - diagnosis | Mycobacterium tuberculosis - pathogenicity | HIV Infections - microbiology | Tuberculosis, Multidrug-Resistant - microbiology | HIV Infections - complications | Tuberculosis, Multidrug-Resistant - therapy | Drug resistance in microorganisms | Public health administration | Forecasts and trends | Tuberculosis | Drug therapy | Epidemics | Chemotherapy | Surveillance | Medical laboratories | Mortality | Drug resistance | Patients | extensively drug-resistant tuberculosis | multidrug-resistant tuberculosis-pregnancy | Review | Diagnosis - epidemiology - extensively drug-resistant tuberculosis - HIV - India - multidrug-resistant tuberculosis -pregnancy - second-line drugs - XDR-TB
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 5/2012, Volume 205, Issue 2, pp. S228 - S240
Journal Article
Trials, ISSN 1745-6215, 06/2013, Volume 14, Issue 1, pp. 170 - 170
Background: Tuberculosis control in sub-Saharan Africa has long been hampered by poor diagnostics and weak health systems. New molecular diagnostics, such as... 
Point-of-care systems | Clinical trial | Molecular diagnostics | Multidrug-resistant tuberculosis | Tuberculosis | HIV | MEDICINE, RESEARCH & EXPERIMENTAL | OF-CARE DIAGNOSIS | FEASIBILITY | LABORATORY DIAGNOSIS | IMPLEMENTATION | XPERT MTB/RIF | TREATMENT INITIATION | RESISTANT TUBERCULOSIS | RIFAMPIN RESISTANCE | POINT | POSITIVE PULMONARY TUBERCULOSIS | Sputum - microbiology | Predictive Value of Tests | Tuberculosis, Pulmonary - microbiology | Coinfection | Laboratories | Humans | Clinical Protocols | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Multidrug-Resistant - diagnosis | Molecular Diagnostic Techniques | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Bacteriological Techniques | HIV Infections - mortality | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - mortality | Risk Assessment | Risk Factors | South Africa - epidemiology | Logistic Models | Mycobacterium tuberculosis - isolation & purification | Point-of-Care Systems | Tuberculosis, Pulmonary - mortality | Tuberculosis, Pulmonary - diagnosis | Ambulatory Care Facilities | Primary Health Care | Research Design | Mycobacterium tuberculosis - growth & development | Rural Health Services | Tuberculosis, Multidrug-Resistant - drug therapy | Virus diseases | Epidemics | Drug resistance in microorganisms | South Africa | HIV (Viruses) | HIV infection
Journal Article
by Merker, Matthias and Merker, Matthias and Blin, Camille and Blin, Camille and Mona, Stefano and Mona, Stefano and Duforet-Frebourg, Nicolas and Duforet-Frebourg, Nicolas and Lecher, Sophie and Lecher, Sophie and Willery, Eve and Willery, Eve and Blum, Michael G B and Blum, Michael G. B and Rüsch-Gerdes, Sabine and Rüsch-Gerdes, Sabine and Mokrousov, Igor and Mokrousov, Igor and Aleksic, Eman and Aleksic, Eman and Allix-Béguec, Caroline and Allix-Béguec, Caroline and Antierens, Annick and Antierens, Annick and Augustynowicz-Kopeć, Ewa and Augustynowicz-Kopeć, Ewa and Ballif, Marie and Ballif, Marie and Barletta, Francesca and Barletta, Francesca and Beck, Hans P.eter and Beck, Hans Peter and Barry, Clifton E and Barry, Clifton E and Bonnet, Maryline and Bonnet, Maryline and Borroni, Emanuele and Borroni, Emanuele and Campos-Herrero, Isolina and Campos-Herrero, Isolina and Cirillo, Daniela and Cirillo, Daniela and Cox, Helen and Cox, Helen and Crowe, Suzanne and Crowe, Suzanne and Crudu, Valeriu and Crudu, Valeriu and Diel, Roland and Diel, Roland and Drobniewski, Francis and Drobniewski, Francis and Fauville-Dufaux, Maryse and Fauville-Dufaux, Maryse and Gagneux, Sébastien and Gagneux, Sébastien and Ghebremichael, Solomon and Ghebremichael, Solomon and Hanekom, Madeleine and Hanekom, Madeleine and Hoffner, Sven and Hoffner, Sven and Jiao, Wei-wei and Jiao, Wei-Wei and Kalon, Stobdan and Kalon, Stobdan and Kohl, Thomas A and Kohl, Thomas A and Kontsevaya, Irina and Kontsevaya, Irina and Lillebæk, Troels and Lillebæk, Troels and Maeda, Shinji and Maeda, Shinji and Nikolayevskyy, Vladyslav and Nikolayevskyy, Vladyslav and Rasmussen, Michael and Rasmussen, Michael and Rastogi, Nalin and Rastogi, Nalin and Samper, Sofia and Samper, Sofia and Sanchez-Padilla, Elisabeth and Sanchez-Padilla, Elisabeth and Savic, Branislava and Savic, Branislava and Shamputa, Isdore C.hola and Shamputa, Isdore Chola and Shen, Adong and Shen, Adong and Sng, Li-Hwei and Sng, Li-Hwei and Stakenas, Petras and Stakenas, Petras and Toit, Kadri and Toit, Kadri and Varaine, Francis and Varaine, Francis and Vukovic, Dragana and Vukovic, Dragana and ...
Nature Genetics, ISSN 1061-4036, 03/2015, Volume 47, Issue 3, pp. 242 - 249
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 2015, Volume 21, Issue 3, pp. 409 - 416
Journal Article
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 09/2014, Volume 18, Issue 9, pp. 1019 - 1025
BACKGROUND: Effective treatment for drug-susceptible tuberculosis (TB) rapidly renders patients noninfectious, long before conversion of sputum acid-fast smear... 
Impact of treatment | Multidrug-resistant tuberculosis | Extensively drug-resistant tuberculosis | Transmission | MYCOBACTERIUM-TUBERCULOSIS | TUBERCLE-BACILLI | SOUTH-AFRICA | INFECTIOUS DISEASES | multidrug-resistant tuberculosis | SETTINGS | CHEMOTHERAPY | VARIABILITY | transmission | impact of treatment | WARD | RESPIRATORY SYSTEM | extensively drug-resistant tuberculosis | PULMONARY TUBERCULOSIS | INFECTION | Sputum - microbiology | Tuberculosis, Pulmonary - microbiology | Air Microbiology | Humans | Middle Aged | Male | Tuberculosis, Pulmonary - drug therapy | Infection Control - methods | Mycobacterium tuberculosis - drug effects | Tuberculin Test | Tuberculosis, Multidrug-Resistant - diagnosis | Cross Infection - transmission | Microbial Sensitivity Tests | Young Adult | Time Factors | Tuberculosis, Multidrug-Resistant - microbiology | Tuberculosis, Multidrug-Resistant - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Retrospective Studies | Antitubercular Agents - therapeutic use | Extensively Drug-Resistant Tuberculosis - drug therapy | Guinea Pigs | Cross Infection - prevention & control | Treatment Outcome | Mycobacterium tuberculosis - isolation & purification | Animals | Extensively Drug-Resistant Tuberculosis - transmission | Tuberculosis, Pulmonary - diagnosis | Cross Infection - microbiology | Adolescent | Cross Infection - diagnosis | Aged | Tuberculosis, Pulmonary - transmission | Tuberculosis, Multidrug-Resistant - drug therapy
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2014, Volume 371, Issue 8, pp. 723 - 732
Journal Article
PLoS Medicine, ISSN 1549-1277, 07/2011, Volume 8, Issue 7, p. e1001067
Journal Article